BIOMAT Database Logo BIOMAT Database Logo

Amiodarone and desethylamiodarone elimination kinetics following withdrawal of long-term amiodarone maintenance therapy. 1985

D Marchiset, and R Bruno, and P Djiane, and J P Cano, and M Benichou, and A Serradimigni

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000638 Amiodarone An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance. Amiobeta,Amiodarex,Amiodarona,Amiodarone Hydrochloride,Amiohexal,Aratac,Braxan,Corbionax,Cordarex,Cordarone,Kordaron,L-3428,Ortacrone,Rytmarone,SKF 33134-A,Tachydaron,Trangorex,Hydrochloride, Amiodarone,L 3428,L3428,SKF 33134 A,SKF 33134A
D001572 Benzofurans Compounds that contain a BENZENE ring fused to a furan ring. Coumarones,Diphenylbenzofuran
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance

Related Publications

D Marchiset, and R Bruno, and P Djiane, and J P Cano, and M Benichou, and A Serradimigni
Amiodarone and desethylamiodarone concentrations in plasma and tissues of surgically treated patients on long-term oral amiodarone treatment.
January 1990, In vivo (Athens, Greece),
D Marchiset, and R Bruno, and P Djiane, and J P Cano, and M Benichou, and A Serradimigni
Interrelationships between serum levels of amiodarone, desethylamiodarone, reverse T3 and the QT interval during long-term amiodarone treatment.
April 1986, American heart journal,
D Marchiset, and R Bruno, and P Djiane, and J P Cano, and M Benichou, and A Serradimigni
Amiodarone and desethylamiodarone distribution in the atrium and adipose tissue of patients undergoing short- and long-term treatment with amiodarone.
July 1986, Journal of the American College of Cardiology,
D Marchiset, and R Bruno, and P Djiane, and J P Cano, and M Benichou, and A Serradimigni
Amiodarone: prolonged elimination following cessation of chronic therapy.
April 1984, American heart journal,
D Marchiset, and R Bruno, and P Djiane, and J P Cano, and M Benichou, and A Serradimigni
Serum amiodarone and desethylamiodarone concentrations following nasogastric versus oral administration.
June 2006, Journal of clinical pharmacy and therapeutics,
D Marchiset, and R Bruno, and P Djiane, and J P Cano, and M Benichou, and A Serradimigni
Breast milk concentrations of amiodarone, desethylamiodarone, and bisoprolol following short-term drug exposure: two case reports.
July 2014, Journal of clinical pharmacology,
D Marchiset, and R Bruno, and P Djiane, and J P Cano, and M Benichou, and A Serradimigni
Prophylactic antiparkinson drug use: II. Withdrawal after long-term maintenance therapy.
August 1991, Journal of clinical pharmacology,
D Marchiset, and R Bruno, and P Djiane, and J P Cano, and M Benichou, and A Serradimigni
Pulmonary sequestration of amiodarone and desethylamiodarone.
June 1986, The Journal of pharmacology and experimental therapeutics,
D Marchiset, and R Bruno, and P Djiane, and J P Cano, and M Benichou, and A Serradimigni
Long-term results of amiodarone therapy.
July 1987, Clinical cardiology,
D Marchiset, and R Bruno, and P Djiane, and J P Cano, and M Benichou, and A Serradimigni
Long-term amiodarone therapy and antithyroid antibodies.
April 1992, The American journal of cardiology,
Copied contents to your clipboard!